Lang Ren
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Lang Ren has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Cheng Chang
Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese Medicine, Nanjing, 210029, China
2 shared publications - Renjun Gu
School of Chinese Medicine Nanjing University of Chinese Medicine Nanjing China
2 shared publications Dongyu Xie
Department of Gastroenterology, Zhenjiang Hospital of Traditional Chinese Medicine, Zhenjiang Affiliated Hospital of Nanjing University of Chinese Medicine, Zhenjiang, 212003, China
1 shared publicationHanlin Dong
The Eighth Clinical Medical School, Guangzhou University of Chinese Medicine, Guangzhou, 510006, China
1 shared publication- Huan Chen
The Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, USA
1 shared publication - Kinyu Shon
Department of Gastroenterology, Nanjing Hospital of Chinese Medicine, Nanjing, 210022, China
1 shared publication
Latest Publications
- Open Access
- 20 February 2026
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 363, 121409
Banxia Xiexin decoction alleviates N-methyl-N′-nitro-N-nitrosoguanidine-induced gastric precancerous lesions by modulating the gastric microbiota
- 20 February 2026
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 363, 121409
Open AccessBanxia Xiexin decoction alleviates N-methyl-N′-nitro-N-nitrosoguanidine-induced gastric precancerous lesions by modulating the gastric microbiota
- Open Access
- 31 December 2024
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 341, 119309
The bitter flavor of Banxia Xiexin decoction activates TAS2R38 to ameliorate low-grade inflammation in the duodenum of mice with functional dyspepsia
- 31 December 2024
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 341, 119309
Open AccessThe bitter flavor of Banxia Xiexin decoction activates TAS2R38 to ameliorate low-grade inflammation in the duodenum of mice with functional dyspepsia